The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

Conway, Gerard, Dewailly, Didier, Diamanti-Kandarakis, Evanthia, Escobar-Morreale, Héctor F, Franks, Stephen, Gambineri, Alessandra, Kelestimur, Fahrettin, Macut, Djuro, Micic, Dragan, Pasquali, Renato, Pfeifer, Marija, Pignatelli, Duarte, Pugeat, Michel, Yildiz, Bulent O·2014·European Journal of Endocrinology
DOI 10.1530/eje-14-0253

Cites (288)

Items 201–285 of 285

  1. The interobserver reliability of off‐line antral follicle counts made from stored three‐dimensional ultrasound data: a comparative study of different measurement techniques
    Kannamannadiar Jayaprakasan, Kate F. Walker, Jeanette S. Clewes, I. R. Johnson, N. J. Raine‐Fenning · 2007 · Ultrasound in Obstetrics and Gynecology
  2. Assessment of androgen concentration in women: liquid chromatography–tandem mass spectrometry and extraction RIA show comparable results
    Femi Janse, Martinus J.C. Eijkemans, Angelique J. Goverde, Eef G.W.M. Lentjes, Annemieke Hoek, Cornelis Bavo Lambalk, Theresa E. Hickey, Bart C.J.M. Fauser, Robert John Norman · 2011 · European Journal of Endocrinology
  3. Ultrasound in polycystic ovary syndrome the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study
    Anna Maria Fulghesu, Stefano L. Angioni, Frau E, Chiara Belosi, Rosanna Apa, Roberto Mioni, N. Xamin, Giampiero Capobianco, Salvatore Dessole, Franca Fruzzetti et al. · 2007 · Human Reproduction
  4. Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute–sponsored Women’s Ischemia Syndrome Evaluation
    C. Noel Bairey Merz, B. Delia Johnson, Sarah L. Berga, Glenn David Braunstein, Steven E. Reís, Vera Bittner · 2006 · Fertility and Sterility
  5. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism
    Yılmaz Şahin, Sermin Dilber, Fahrettin Keleştimur · 2001 · Fertility and Sterility
  6. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method
    Lerchbaum, E., Schwetz, V., Giuliani, A., Obermayer-Pietsch, B. · 2013 · Human Reproduction
  7. Endocrine consequences of premature pubarche in post‐pubertal Caucasian girls
    Taly Meas, Didier Chevenne, Elisabeth Thibaud, Juliane Léger, Sylvie Cabrol, Paul Czernichow, Claire Lévy‐Marchal · 2002 · Clinical Endocrinology
  8. Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior
    Pei‐Yu Wang, Anna Protheroe, Andrew N. Clarkson, Floriane M. Imhoff, Kyoko Koishi, Ian Stuart McLennan · 2009 · Proceedings of the National Academy of Sciences
  9. Insulin Resistance in Non-Obese Women with Polycystic Ovary Syndrome: Relation to Byproducts of Oxidative Stress
    Djuro Μacut, Tatjana P. Simic, Alexei Lissounov, Marija S. Pljesa-Ercegovac, Ivana Božić Antić, Tatjana I. Djukic, Jelica Bjekić-Macut, Marija G. Matic, Milan S. Petakov, Sonja R. Suvakov et al. · 2011 · Experimental and Clinical Endocrinology & Diabetes
  10. Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis: Metformin vs thiazolidinediones for PCOS
    Li, X-J., Yu, Y-X., Liu, C-Q., Zhang, W., Zhang, H-J., Yan, B., Wang, L-Y., Yang, S-Y., Zhang, S-H. · 2011 · Clinical Endocrinology
  11. Androgen Profiling by Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) in Healthy Normal-Weight Ovulatory and Anovulatory Late Adolescent and Young Women
    Flaminia Fanelli, Alessandra Gambineri, Ilaria Belluomo, Andrea Repaci, Valentina Diana Di Lallo, Guido Di Dalmazi, Marco Mezzullo, Olga Prontera, Gaia Cuomo, Laura Zanotti et al. · 2013 · The Journal of Clinical Endocrinology & Metabolism
  12. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
    Tomlinson, J., Millward, A., Stenhouse, E., Pinkney, J. · 2010 · Diabetic Medicine
  13. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome
    Susanne M. Veltman-Verhulst, Timon W. van Haeften, Marinus J.C. Eijkemans, Harold W. de Valk, Bart C.J.M. Fauser, Angelique J. Goverde · 2010 · Human Reproduction
  14. Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
    Signe S. Torekov, Sten Madsbad, Jens Juul Holst · 2011 · Obesity Reviews
  15. Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin
    Nathalie Lebeurrier, Séverine Launay, Richard Macrez, Eric Maubert, Hélène Legros, Arnaud Leclerc, Soazik P. Jamin, Jean‐Yves Picard, Stéphane Marret, Vincent Laudenbach et al. · 2008 · Journal of Cell Science
  16. Does PCOS have developmental origins?
    Stephen Franks, Sarah L. Berga · 2011 · Fertility and Sterility
  17. Polymorphisms in theSHBGGene Influence Serum SHBG Levels in Women with Polycystic Ovary Syndrome
    Edmond P. Wickham, Kathryn G. Ewens, Richard S. Legro, Andrea Elizabeth Dunaif, John E. Nestler, Jerome F. Strauss · 2011 · The Journal of Clinical Endocrinology & Metabolism
  18. Sex Hormone-Binding Globulin, Oligomenorrhea, Polycystic Ovary Syndrome, and Childhood Insulin at Age 14 Years Predict Metabolic Syndrome and Class III Obesity at Age 24 Years
    Glueck, Charles J., Morrison, John A., Daniels, Stephen, Wang, Ping, Stroop, Davis · 2011 · The Journal of Pediatrics
  19. Glucose intolerance states in women with the polycystic ovary syndrome
    Riccardo Pasquali, Alessandra Gambineri · 2013 · Journal of Endocrinological Investigation
  20. Electrolysis and thermolysis for permanent hair removal
    Richard F. Wagner, John M. Tornich, Donald J. Grande · 1985 · Journal of the American Academy of Dermatology
  21. Fetal programming of polycystic ovary syndrome
    Esra Bahar Gür · 2015 · World Journal of Diabetes
  22. Lipid and lipoprotein profile in women with polycystic ovary syndromeThis article is one of a selection of papers published in the special issue Bridging the Gap: Where Progress in Cardiovascular and Neurophysiologic Research Meet.
    Djuro Μacut, Dimitrios Panidis, B. Glišić, Nikolaos Spanos, Milan S. Petakov, Jelica Bjekić, Olivera P. Stanojlović, David Rousso, Anargyros Kourtis, Ivana Božić Antić et al. · 2008 · Canadian Journal of Physiology and Pharmacology
  23. Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome
    Sarantis Livadas, Sofia Chaskou, Anna Kandaraki, Georgios Skourletos, Frangiskos Economou, María Christou, Georgios Boutzios, Athanasios Karachalios, Aristea Zerva, Xenofon Xyrafis et al. · 2011 · Clinical Endocrinology
  24. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up
    Hudecova, Miriam, Holte, Jan, Olovsson, Matts, Larsson, Anders, Berne, Christian, Sundstrom-Poromaa, Inger · 2011 · Fertility and Sterility
  25. Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women
    Babak Mokhlesi, Bert Scoccia, Theodore Mazzone, Susan Sam · 2012 · Fertility and Sterility
  26. Medical management of metabolic dysfunction in PCOS
    Antoni J. Dulęba · 2011 · Steroids
  27. Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin
    Alessandra Gambineri, Robert K. Semple, G Forlani, Silvia Genghini, Ilaria Grassi, Caroline S. S. Hyden, Uberto Pagotto, Stephen O’Rahilly, Riccardo Pasquali · 2008 · European Journal of Endocrinology
  28. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women
    Lourdes Ibáñez, Adriana Jaramillo, Angela Ferrer, Francis de Zegher · 2005 · Human Reproduction
  29. Defining the role of bariatric surgery in polycystic ovarian syndrome patients
    Shaveta M Malik · 2012 · World Journal of Diabetes
  30. Greater Arterial Stiffness in Polycystic Ovary Syndrome (PCOS) Is an Obesity- But Not a PCOS-Associated Phenomenon
    Iris J. G. Ketel, Coen D.A. Stehouwer, Ronald M.A. Henry, Erik H. Serné, Peter G.A. Hompes, Roy Homburg, Yvo Michiel Smulders, Cornelis Bavo Lambalk · 2010 · The Journal of Clinical Endocrinology & Metabolism
  31. Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome
    Elizabeth Jedel, Deborah Gustafson, Margda Wærn, Yrsa Bergmann Sverrisdóttir, Mikael Landén, Per Olof Janson, Fernand Labrie, Claes Ohlsson, Elisabet Stener‐Victorin · 2011 · Psychoneuroendocrinology
  32. Diabetes and oral contraception
    Pierre Gourdy · 2012 · Best Practice & Research Clinical Endocrinology & Metabolism
  33. A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism
    İptisam İpek Müderris, Fahrı Bayram, Yılmaz Şahin, Fahrettin Keleştimur · 1997 · Fertility and Sterility
  34. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors
    Enrico Carmina, Anna Maria Campagna, Roger A. Lobo · 2013 · Human Reproduction
  35. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels
    Lana Škrgatić, Dinka Pavičić Baldani, J.Z. Cerne, Polonca Ferk, Ksenija Geršak · 2011 · The Journal of Steroid Biochemistry and Molecular Biology
  36. Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism
    Fahrettin Keleştimur, Yılmaz Şahin · 1998 · Fertility and Sterility
  37. Environmental and genetic factors influence age at menarche in women with polycystic ovary syndrome
    Jessica Carroll, Richa Saxena, Corrine Kolka Welt · 2012 · Journal of Pediatric Endocrinology and Metabolism
  38. Screening for Sleep-Disordered Breathing and Excessive Daytime Sleepiness in Adolescent Girls with Polycystic Ovarian Syndrome
    Kiran Nandalike, Temima Strauss, Chhavi Agarwal, Susan M. Coupey, Sanghun Sin, Swapnil N. Rajpathak, Hillel W. Cohen, Raanan Arens · 2011 · The Journal of Pediatrics
  39. Cardiovascular Risk and Subclinical Cardiovascular Disease in Polycystic Ovary Syndrome
    Katica Bajuk Studen, Mojca Jensterle Sever, Marija Pfeifer · 2012 · Frontiers of hormone research
  40. In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone
    A. Mazza, Barbara Fruci, Pietro Hiram Guzzi, B D'Orrico, Roberta Malaguarnera, Pierangelo Veltri, Antonietta Fava, Antonino Belfiore · 2013 · Nutrition Metabolism and Cardiovascular Diseases
  41. Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome
    Ayla Harmancı, Neşe Çınar, Miyase Bayraktar, Bülent Okan Yıldız · 2012 · Clinical Endocrinology
  42. Proteomic and metabolomic approaches to the study of polycystic ovary syndrome
    María Rosa Insenser, Rafael Montes‐Nieto, Mora Murri, Héctor Francisco Escobar-Morreale · 2013 · Molecular and Cellular Endocrinology
  43. THERAPY OF ENDOCRINE DISEASE: Treatment of hirsutism in the polycystic ovary syndrome
    Pasquali, Renato, Gambineri, Alessandra · 2014 · European Journal of Endocrinology
  44. Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome.
    2013 · PubMed
  45. A Detailed Investigation of Hirsutism in a Turkish Population: Idiopathic Hyperandrogenemia as a Perplexing Issue
    K. Unluhizarci, C Gökçe, Habibe Nur Atmaca, Fahrı Bayram, Fahrettin Keleştimur · 2004 · Experimental and Clinical Endocrinology & Diabetes
  46. Hyperandrogenic Oligomenorrhea and Metabolic Risks Across Menopausal Transition
    Alex Joel Polotsky, Amanda A. Allshouse, Sybil L. Crawford, Sioḃán D. Harlow, Naila Khalil, Rasa Kazlauskaite, Nanette Santoro, Richard S. Legro · 2014 · The Journal of Clinical Endocrinology & Metabolism
  47. Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome—a long-term follow-up study
    Schmidt, Johanna, Dahlgren, Eva, Brännström, Mats, Landin‐Wilhelmsen, Kerstin · 2012 · Clinical Endocrinology
  48. Breast size increment during pregnancy and breastfeeding in mothers with polycystic ovary syndrome: a follow‐up study of a randomised controlled trial on metformin versus placebo
    Eszter Vanky, JJ Nordskar, Helene Lorgen Leithe, AK Hjorth‐Hansen, Marit Martinussen, Sven Magnus Carlsen · 2012 · BJOG An International Journal of Obstetrics & Gynaecology
  49. Association of the CAG repeat polymorphisms in androgen receptor gene with polycystic ovary syndrome: A systemic review and meta-analysis
    Tao Zhang, Wenqing Liang, Min Fang, Jianmin Yu, Ya Ni, Zhongxiang Li · 2013 · Gene
  50. Effects of Thiazolidinediones on Polycystic Ovary Syndrome: a Meta-analysis of Randomized Placebo-Controlled Trials
    Du, Qiang, Yang, Sheng, Wang, Yan-Jun, Wu, Bo, Zhao, Yue-Yang, Fan, Bin · 2012 · Advances in Therapy
  51. Ovarian hyperthecosis on grayscale and color Doppler ultrasound
    Pascal Rousset, Anne Gompel, Sophie Christin‐Maître, M. Pugeat, Danielle Hugol, Michel A. Ghossain, Jean‐Noël Buy · 2008 · Ultrasound in Obstetrics and Gynecology
  52. Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome
    Alessandra Gambineri, Andrea Repaci, Laura Patton, Ilaria Grassi, Patrizia Pocognoli, G. E. Cognigni, Francesca Pasqui, Uberto Pagotto, Riccardo Pasquali · 2009 · Nutrition Metabolism and Cardiovascular Diseases
  53. Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome
    Hurd, William W., Abdel-Rahman, Mohamed Y., Ismail, Salah A., Abdellah, Mostafa A., Schmotzer, Christine L., Sood, Ajay · 2011 · Fertility and Sterility
  54. Non-Classic Adrenal Hyperplasia due to the Deficiency of 21-Hydroxylase and Its Relation to Polycystic Ovarian Syndrome
    Duarte Pignatelli · 2012 · Frontiers of hormone research
  55. Polycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes offspring
    Georgios Boutzios, Sarantis Livadas, Christina Piperi, Nicolaos Vitoratos, Christos Adamopoulos, Dimitrios Hassiakos, Christos R Iavazzo, Evanthia Diamanti‐Kandarakis · 2012 · Fertility and Sterility
  56. Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism
    Santiago Palacios, Jean‐Michel Foidart, Andrea Ricardo Genazzani · 2006 · Maturitas
  57. Statins in the Treatment of Polycystic Ovary Syndrome
    Pinar H. Kodaman, Antoni J. Dulęba · 2008 · Seminars in Reproductive Medicine
  58. Relative Contributions of Oligomenorrhea and Hyperandrogenemia to the Risk of Metabolic Syndrome in Midlife Women
    Alex Joel Polotsky, Amanda A. Allshouse, Sybil L. Crawford, Sioḃán D. Harlow, Naila Khalil, Nanette Santoro, Richard S. Legro · 2012 · The Journal of Clinical Endocrinology & Metabolism
  59. Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features
    Melissa Pawelczak, Lisa Kenigsberg, Sarah Sarvis Milla, Yinghua Liu, Bina Cherryl Shah · 2012 · Journal of Pediatric Endocrinology and Metabolism
  60. The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism
    Ebru Dıkensoy, Özcan Balat, Sadrettin Pençe, Cenk Akçalı, Hülya Çiçek · 2008 · Archives of Gynecology and Obstetrics
  61. Recommendations for investigation of hyperandrogenism
    M. Pugeat, Henri Déchaud, Véronique Raverot, Anne Denuzière, Richard Cohen, Philippe Boudou · 2010 · Annales d Endocrinologie
  62. Strong and positive association of Endothelin-1 with AGEs in PCOS: A causal relationship or a bystander?
    Charikleia D. Christakou, Frangiskos Economou, Sarantis Livadas, Christina Piperi, Christos Adamopoulos, Evangelos Marinakis, Evanthia Diamanti‐Kandarakis · 2011 · HORMONES
  63. LH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo/amenorrhoea
    M. L. Hendriks, J Brouwer, Peter G.A. Hompes, Roy Homburg, Cornelis Bavo Lambalk · 2008 · Reproductive BioMedicine Online
  64. Skeletal muscle mitochondrial function in polycystic ovarian syndrome
    Rabøl, Rasmus, Svendsen, Pernille F, Skovbro, Mette, Boushel, Robert, Schjerling, Peter, Nilas, Lisbeth, Madsbad, Sten, Dela, Flemming · 2011 · European Journal of Endocrinology
  65. Seasonal effects on vitamin D status influence outcomes of lifestyle intervention in overweight and obese women with polycystic ovary syndrome
    Rebecca Louise Thomson, Simon J Spedding, Grant David Brinkworth, Manny Noakes, Jonathan David Buckley · 2013 · Fertility and Sterility
  66. Laparoscopic electrocautery of the ovaries versus recombinant FSH in clomiphene citrate-resistant polycystic ovary syndrome. Impact on women's health-related quality of life
    Madelon van Wely, Neriman Bayram, Patrick M. Bossuyt, Fulco van der Veen · 2004 · Human Reproduction
  67. Measurement of serum testosterone using high-performance liquid chromatography/tandem mass spectrometry
    Faye B. Vicente, Frederick A. Smith, Rafael Sierra, Sihe Wang · 2005 · Clinical Chemistry and Laboratory Medicine (CCLM)
  68. The protein profile of mouse mature cumulus–oocyte complex
    Yan Meng, Xiaohui Liu, Xiang Ma, Ya Shen, Lu Fan, Jing Leng, Jiayin Liu, Jiahao Sha · 2007 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  69. MECHANISMS IN ENDOCRINOLOGY: Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome
    Nicolas Galazis, Thalia Afxentiou, Mikalena Xenophontos, Evanthia Diamanti‐Kandarakis, William Atiomo · 2012 · European Journal of Endocrinology
  70. Retrospective observational study on the effects and tolerability of flutamide in a large population of patients with various kinds of hirsutism over a 15-year period
    Roberto Paradisi, Stefano Venturoli · 2010 · European Journal of Endocrinology
  71. Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
    Flaminia Fanelli, Alessandra Gambineri, Marco Mezzullo, Valentina Vicennati, Carla Pelusi, Renato Pasquali, Uberto Pagotto · 2013 · Reviews in Endocrine and Metabolic Disorders
  72. Obesity impairs general health‐related quality of life (HR‐QoL) in premenopausal women to a greater extent than polycystic ovary syndrome (PCOS)
    Francisco Álvarez‐Blasco, Manuel Luque‐Ramírez, Héctor Francisco Escobar-Morreale · 2010 · Clinical Endocrinology
  73. Psychological gender of patients with polycystic ovary syndrome
    Robert Kowalczyk, Violetta Skrzypulec, Zbigniew Lew-Starowicz, Krzysztof Nowosielski, Bartosz Grabski, Wojciech Merk · 2012 · Acta Obstetricia Et Gynecologica Scandinavica
  74. Panel Recommends Easing Restrictions on Rosiglitazone Despite Concerns About Cardiovascular Safety
    Mike Mitka · 2013 · JAMA
  75. Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome
    Susanne M. Veltman-Verhulst, Angelique J. Goverde, Timon W. van Haeften, Bart C.J.M. Fauser · 2013 · Human Reproduction
  76. Insulin-induced capillary recruitment is impaired in both lean and obese women with PCOS
    Iris J. G. Ketel, Erik H. Serné, Richard G. IJzerman, Ted J. M. Korsen, Jos W. R. Twisk, Peter G.A. Hompes, Yvo Michiel Smulders, Roy Homburg, L. Vorstermans, Coen D.A. Stehouwer et al. · 2011 · Human Reproduction
  77. Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome
    Carley Gomez-Meade · 2013 · World Journal of Diabetes
  78. Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters
    Jalini Joharatnam, Thomas M. Barber, Lisa J. Webber, Gerard S. Conway, Mark I. McCarthy, Stephen Franks · 2011 · Clinical Endocrinology
  79. The Effect of Bariatric Surgery on Female Reproductive Function
    Lisa Moran, Robert John Norman · 2012 · The Journal of Clinical Endocrinology & Metabolism
  80. Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause
    Marios C Markopoulos, George Valsamakis, Evangelia E. Kouskouni, Anastassios Boutsiadis, Ioannis Papassotiriou, George K. Creatsas, George P. Mastorakos · 2012 · European Journal of Endocrinology
  81. Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome
    Tao Tao, Shengxian Li, Aimin Zhao, Yanyun Zhang, Wei Yong Liu · 2012 · European Journal of Endocrinology
  82. Polycystic Ovary Syndrome: Is Obesity a Symptom?
    Bülent Okan Yıldız · 2013 · Women s Health
  83. Association of anthropometric, androgenic and insulin-related features with polymorphisms in exon 8 of SHBG gene in women with polycystic ovary syndrome
    Burak Hacıhanefioğlu, Bekir Aybey, Yavuz Hakan Özön, Hakan Berkil, Kubilay Karşıdağ · 2013 · Gynecological Endocrinology
  84. Application of proteomics to the study of polycystic ovary syndrome.
    María Rosa Insenser, Héctor Francisco Escobar-Morreale · 2011 · PubMed
  85. Hirsutism – From Diagnosis to Use of Antiandrogens
    Kürşad Ünlühızarcı, Züleyha Karaca, Fahrettin Keleştimur · 2012 · Frontiers of hormone research